Product Reports Resources Pricing Login Book a demo

Hutom

Health Tech & Medtech · Seoul, South Korea · Founded 2017

AI surgical platform for procedural planning and navigation MoreLess

Hutom is a medical technology company founded in 2017 by surgeon Dr. Woo Jin Hyung, who serves as the CEO. The company is headquartered in Seoul, South Korea. Dr. Hyung, a professor at Yonsei University College of Medicine and chief of upper gastrointestinal surgery at Severance Hospital, was motivated by his surgical experience to address the performance gap among surgeons by leveraging AI and big data. He performed the first robotic gastric surgery in South Korea in 2005 and recognized that digital technology could help standardize surgical outcomes.

The company has developed an AI-powered surgical platform that provides a "Total Surgical Patient Care solution" to assist surgeons pre-operatively, intra-operatively, and post-operatively. Its core product, RUS (Reshaping and Unraveling Surgery), is a surgical navigation platform that uses AI to convert 2D CT images into interactive 3D anatomical models. This technology supports surgeons in planning procedures and provides real-time navigation during operations. The platform includes patented technologies for automatic organ segmentation, calibration of veins and arteries, and modeling to predict abdominal changes during surgery. Hutom's platform is comprised of three main components: RUS for 3D visualization, ViHub for surgical video data analysis, and SurgGram for post-operative review.

Hutom serves the healthcare market, targeting surgeons and hospitals. In May 2024, the company entered into a co-promotion agreement with Johnson & Johnson MedTech Korea to expand the use of its RUS platform for gastric and kidney cancer surgeries in the country. The company has received significant funding, including a Series B round of $14.3 million in January 2022 from investors such as IMM Investment, Samsung Venture Investment, and KB Investment. The platform has gained regulatory approvals, including a Class II device approval from South Korea's Ministry of Food and Drug Safety in 2021 and FDA 510(k) clearance for 'RUS Stomach' in the U.S.

Keywords: surgical AI, medical imaging, 3D surgical mapping, surgical navigation, healthcare technology, surgical video analysis, preoperative planning, intraoperative navigation, medical software, robotic surgery, laparoscopic surgery, partial nephrectomy, gastric surgery, oncology, digital surgery, medical devices, health-tech, surgical intelligence, anatomical modeling, computer-assisted surgery

Company overview

Hutom company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2017
Headquarters
Seoul, South Korea
Employees
46
Open positions
None listed
Dealroom signal
73.6
client focusb2btechnologyArtificial Intelligencetechnology3D TechnologytechnologyDeep TechtechnologyMachine LearningtechnologyComputer Visionsub industryMedical Devicessub industryHealth Platformbusiness modelSaaSindustryHealthsectorSurgerysectorMedical ImagingsectorSpinoutsectorSurgical Equipment

Valuation & funding

Hutom funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Mar 2024 $39M $156M Undisclosed
SERIES BOther financing Jan 2022 $14M $57M Samsung Ventures · Quantum Ventures Korea · Korea Investment Partners · IMM Investment
SERIES AOther financing Jul 2020 $4.2M $17M KB Investment · IMM Investment
SERIES AOther financing Mar 2018 $3.4M $13M LSK Investment
SPINOUTOther financing Jan 2017 $0 Yonsei University
Showing 5 recorded eventsUnlock the complete deal history →

Growth signals

Hutom website traffic

Latest recorded traffic for Hutom is 550 monthly website visits, down 86.9% over the last three months. Hutom's team declined 8% over the past year.

Latest monthly visits550 3-month web change-86.9% 1-year team growth-8%
Monthly website visits59 observations · Jun 2020–Jun 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Hutom compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Hutom's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Hutom's cap table

Sourced from Dealroom's funding and investor records.

Series A 7 investors entered at this stage
LSK Investment
KB Investment
IMM Investment
Samsung Ventures
Quantum Ventures Korea
Korea Investment Partners
Nau IB Capital
Other known 1 additional known investor
Yonsei University

Global footprint

Where Hutom has talent and traffic

Workforce by country
2 countries with
team presence
🇰🇷 South Korea96.5%
🇸🇦 Saudi Arabia3.5%
2 countries shown

In the news

Latest news about Hutom

Recent press, funding announcements, and product moves mentioning Hutom — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Hutom

An AI-synthesized read of the highest-engagement posts about Hutom on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hutom’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.